Equity · Healthcare
AZN
NYSEAstraZeneca (AZN)
The line runs 158 USD on 3 August through 186.70 USD on 30 October, on a scale from 150 to 190. Days the market did not trade hold the previous close, flat.
- Revenue, year to Dec 2025
- 58.7B USD
- EPS, diluted, year to Dec 2025
- 6.54 USD
- 52-week range
- 81.15 USD – 209.16 USD
- Avg volume
- 145.0K
- Mentions, 30 days
- 2
as of Oct 30, 2026
Have AstraZeneca (AZN) insiders bought or sold shares recently?
In the 90 days to 2 Nov 2026, AstraZeneca insiders reported 1 open-market purchase and no sales (SEC Form 4).
Form 4, 90 days to 2 Nov 2026, newest reported trade 8 Aug 2026
Buys 1Sells 0Net bought $3KOther filings 3
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 08 Aug 2026 | Sharma ManiSee Remarks | Buy | 20 | 3K USD |
3 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 06 Oct 2026 | Sharma ManiSee remarks | Award | 2 | 320 USD |
| 08 Sep 2026 | Sharma ManiSee Remarks | Award | 1 | 163 USD |
| 06 Aug 2026 | Sharma ManiSVP, Group Controller | Award | 2 | 327 USD |
Which funds hold AstraZeneca (AZN)?
11 of the 45 institutional funds we track reported a AstraZeneca position for the quarter ended 30 Jun 2026 — a combined 3.2B USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Fisher Asset Management | Held (±25%) | 11,146,292 | 2.1B USD | +2.8% |
| D. E. Shaw & Co. | Added | 1,094,593 | 207.6M USD | +4,277.5% |
| Citadel Advisors | Trimmed | 970,043 | 183.9M USD | −48.1% |
| Marshall Wace | Added | 841,164 | 159.5M USD | +70.8% |
| Point72 Asset Management | Trimmed | 711,547 | 134.9M USD | −42.3% |
| Man Group | Held (±25%) | 683,112 | 128.0M USD | +8.7% |
| Millennium Management | Trimmed | 581,913 | 110.3M USD | −55.3% |
| AQR Capital Management | Held (±25%) | 400,938 | 75.0M USD | +8.4% |
| Two Sigma Investments | Added | 329,087 | 62.4M USD | +62.1% |
| Glenview Capital Management | New position | 184,279 | 34.9M USD |
Showing the 10 largest of 11 reported positions. The figures above count all of them.
Have members of Congress traded AstraZeneca (AZN)?
The most recent congressional trade disclosed in AstraZeneca is a purchase by Julia Letlow (house, LA), dated 08 Dec 2025.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 08 Dec 2025 | Julia Letlowhouse · Republican–LA | Purchase | 1K USD–15K USD | 36 days |
| 19 Nov 2025 | Gilbert Ray Cisneros, Jr.house · Democrat–CA | Purchase | 1K USD–15K USD | 26 days |
| 31 Oct 2025 | Lisa C. McClainhouse · Republican–MI | Sale | 1K USD–15K USD | 21 days |
| 30 Oct 2025 | Lisa C. McClainhouse · Republican–MI | Purchase | 1K USD–15K USD | 22 days |
| 30 Oct 2025 | Lisa C. McClainhouse · Republican–MI | Sale | 1K USD–15K USD | 22 days |
| 21 Oct 2025 | Gilbert Ray Cisneros, Jr.house · Democrat–CA | Purchase | 1K USD–15K USD | 28 days |
| 23 Sep 2025 | Val T. Hoylehouse · Democrat–OR | Sale | 1K USD–15K USD | 17 days |
| 22 Jul 2025 | Lisa C. McClainhouse · Republican–MI | Purchase | 1K USD–15K USD | 22 days |
What has been filed or recorded for AstraZeneca (AZN)?
The filings we hold for AstraZeneca, newest first: 10 fails-to-deliver days and 5 reported financial figures, the latest dated 14 Oct 2026.
| And | ||||
|---|---|---|---|---|
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 10,192 shares | 1.6M USD notional |
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 1,746 shares | 276K USD notional |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 300 shares | 48K USD notional |
| 08 Oct 2026 | Fails to deliver | Shares failed to deliver | 27 shares | 4K USD notional |
| 07 Oct 2026 | Fails to deliver | Shares failed to deliver | 73,264 shares | 11.6M USD notional |
| 30 Sep 2026 | Fails to deliver | Shares failed to deliver | 302 shares | 50K USD notional |
| 24 Sep 2026 | Fails to deliver | Shares failed to deliver | 3 shares | 490 USD notional |
| 23 Sep 2026 | Fails to deliver | Shares failed to deliver | 205 shares | 35K USD notional |
| 21 Sep 2026 | Fails to deliver | Shares failed to deliver | 201 shares | 33K USD notional |
| 17 Sep 2026 | Fails to deliver | Shares failed to deliver | 14,903 shares | 2.4M USD notional |
| 31 Dec 2025 | Financials | Revenue | 58.7B USD | fiscal year |
| 31 Dec 2025 | Financials | Profit loss attributable to owners of parent | 10.2B USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted earnings loss per share | 6.54 USD | fiscal year |
| 31 Dec 2025 | Financials | Total assets | 114.1B USD | at period end |
| 31 Dec 2025 | Financials | Equity attributable to owners of parent | 48.7B USD | at period end |
What is Reddit saying about AstraZeneca (AZN)?
Reddit mentioned AZN 2 times in the 30 days to 1 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 0% read bullish, 50% bearish and 50% neither. Reddit data updated 1 November 2026.
30-day window, Method
Mentions, 30 days 2Communities 1
How do Reddit mentions of AstraZeneca (AZN) compare with its price?
Share ↗
Where AstraZeneca (AZN) is discussed
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 100% | 2 | −0.06 |
AstraZeneca (AZN): frequently asked questions
What did AstraZeneca shares close at?
AstraZeneca closed at 186.70 USD on 30 Oct 2026, up 6.99% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is AstraZeneca’s revenue?
AstraZeneca reported revenue of 58.7B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have AstraZeneca insiders bought or sold shares recently?
In the 90 days to 2 Nov 2026, AstraZeneca insiders reported 1 open-market purchase and no sales (SEC Form 4). A further 3 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own AstraZeneca?
11 of the 45 funds we track reported a AstraZeneca position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Fisher Asset Management, D. E. Shaw & Co. and Citadel Advisors. See Funds
Have members of Congress traded AstraZeneca?
Yes. 17 trades in AstraZeneca appear in the congressional disclosures we hold; the latest is a purchase by Julia Letlow (House, LA) dated 8 Dec 2025, filed 13 Jan 2026. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
What is Reddit saying about AstraZeneca?
AstraZeneca was mentioned 1 times in the last 7 days across the finance subreddits we track, and 2 times over the trailing 30 days. Of the 2 mentions scored for sentiment, 0% read bullish and 50% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 31 Dec 2025